Latest
MarketsMojo Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 185
- Sources here
- 19
- Companies here
- 10
Search results
Stored financial headlines
Active search
185 matching headlines
Ticker or company: MANGMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Nuclea’s planned Moltex deal could add 80 nuclear patents
Mangoceuticals' merger partner, Nuclea Energy, Inc., has entered into a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy, which is currently in administration. The acquisition includes intellectual property for Moltex’s SSR‑W advanced molten salt reactor, WATSS spent-fuel recycling process, and the …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
Mangoceuticals Inc.'s merger partner, Nuclea Energy, Inc., has entered into a definitive agreement to acquire advanced nuclear technology assets from Moltex Energy Limited. This acquisition includes Moltex's Stable Salt Reactor–Wasteburner (SSR-W) and Waste To Stable Salt (WATSS) spent nuclear fuel recycling process, along with …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals, Inc. (MGRX) Stock Price, News, Quote & History
This Yahoo Finance page provides a comprehensive overview of Mangoceuticals, Inc. (MGRX) stock, including its current price, historical data, financial metrics, and company profile. MGRX is engaged in the development and sale of men's wellness products through a telemedicine platform, offering brands like Mango, …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure
Nuclea Energy Inc., a merger partner of Mangoceuticals, has signed a Memorandum of Understanding with New Mining Co. to collaborate on the deployment of behind-the-meter modular reactors for high-density computing infrastructure. This partnership aims to provide reliable, carbon-free, and cost-effective power solutions for data …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Bitcoin miner explores modular reactors for up to 100 MWe
Mangoceuticals announced that its merger partner, Nuclea Energy Inc., signed a non-binding MOU with New Mining Co. to assess the deployment of Nuclea's modular reactor technology for New Mining's high-density computing and Bitcoin mining operations. The evaluation will proceed in phases, starting with engineering …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU
Mangoceuticals, Inc. announced that its merger partner's subsidiary, Nuclea Energy USA Inc., signed a memorandum of understanding (MOU) with the Utah Office of Energy Development. This MOU aims to explore siting a nuclear test reactor at the Utah San Rafael Energy Lab to advance …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Why is Mangoceuticals stock surging today?
Mangoceuticals (MGRX) stock surged over 31% in pre-open trading after its merger partner, Nuclea Energy Inc., announced a key regulatory milestone for its Morpheus microreactor program. This development involves a memorandum of understanding to explore siting a nuclear test reactor in Utah, bolstering investor …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress
Mangoceuticals (MGRX) has received a second 180-day extension from Nasdaq, pushing its compliance deadline to February 1, 2027, to restore its stock price above $1.00. This extension provides flexibility as the company advances a definitive business combination agreement with Nuclea Energy Inc., an advanced …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Utah Lab and Nuclea Explore Morpheus Test-Reactor Site
Mangoceuticals' merger partner, Nuclea Energy USA, has signed a Memorandum of Understanding (MOU) with the Utah Office of Energy Development to explore siting a nuclear test reactor for its Morpheus microreactor at the Utah San Rafael Energy Lab. This agreement is a significant step …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why
Mangoceuticals (MGRX) stock surged over 49% after hours following news that its merger partner, Nuclea Energy Inc., through its subsidiary Nuclea Energy USA Inc., signed a memorandum of understanding with Utah's Office of Energy Development. This MOU explores siting a nuclear test reactor for …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Wondering what's happening in today's after-hours session?
This article provides an overview of the top gainers and losers in the US after-hours trading session on Wednesday, August 5, 2026. It highlights several companies, including MANGOCEUTICALS INC (MGRX) and CREATIVE MEDICAL TECHNOLOGY (CELZ) as top gainers, and YXT.COM GROUP HOLDING LTD (YXT) …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
Mangoceuticals' merger partner, Nuclea Energy, has signed a Memorandum of Understanding (MOU) with the Utah Office of Energy Development to explore siting a nuclear test reactor for its Morpheus microreactor at the Utah San Rafael Energy Lab. This partnership aims to advance the research, …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals Has Until Feb. 1, 2027 to Meet Nasdaq's $1 Bid Rule
Mangoceuticals (NASDAQ: MGRX) has received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, setting a new deadline of February 1, 2027. The company may consider a reverse stock split if necessary to meet the requirement, which involves …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals Granted 180-Day Extension by Nasdaq to
Mangoceuticals Inc. (NASDAQ: MGRX) has received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, pushing the deadline to February 1, 2027. The company is simultaneously advancing its business combination with Nuclea Energy Inc., which is developing the Morpheus …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal
Mangoceuticals (NASDAQ: MGRX) has secured an additional 180-day extension from Nasdaq to meet the minimum bid price requirement, pushing the deadline to February 1, 2027. This extension provides the company flexibility as it progresses with a definitive business combination agreement with Nuclea Energy Inc., …
MGRX
main company
Sharemaestro market context
Trend signal started
52 weeks -69.1% · Next-week setup negative 44.7%